Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
The healthcare technology provider's presentation will stream live and remain archived on its website at 12:45 p.m. EDT on Sept. 9.
Archived explainer. For the current picture see today's OMCL page.
OMNICELL INC (OMCL) is up +6.29% in the latest session. Our newswire has captured 1 story on OMCL across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 55/100).
OMCL stock rose 6.29% to $35.16 on Friday, driven by renewed investor interest ahead of the company's scheduled presentation at the Wells Fargo 21st Annual Healthcare Conference. The stock opened lower but reversed sharply during the session, closing near its intraday high. The move followed a series of recent updates from key analysts and revised guidance from the company itself.
Omnicell is set to present at the Wells Fargo Healthcare Conference on Sept. 9 at 12:45 p.m. EDT. The presentation will be streamed live and archived on the company's website. This event is likely to draw attention from investors and analysts as Omnicell continues to position itself in the healthcare technology sector. Recent analyst activity has also been notable. Piper Sandler, Wells Fargo, and Keybanc all maintain Overweight ratings on the stock but have lowered their price targets to $45, $50, and $65 respectively. Meanwhile, Omnicell issued revised Q3 and FY2026 guidance, raising its adjusted EPS outlook and narrowing its sales forecast. These updates suggest the company is navigating its path with more clarity.
The stock opened at $32.82, a 0.8% gap down from the previous close, but climbed steadily throughout the session to reach a high of $35.22. It closed at $35.16, a 6.29% increase. The session saw 0.8 million shares traded, which is 1.1 times the 3-month average. The stock remains within its 52-week range of $29.06 to $55.00 and is currently trading with a P/E of 39.3. On the 52-week tape, the stock printed 40 fresh 52-week highs and two fresh 52-week lows on Aug. 31. Recent insider transactions include two sales totaling $584K, with the most recent filing on Aug. 18.
The presentation at the Wells Fargo Healthcare Conference on Sept. 9 will be a key event to monitor for investor sentiment and potential market reaction. The company's updated guidance and analyst ratings provide a backdrop for further analysis of its strategic direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
The healthcare technology provider's presentation will stream live and remain archived on its website at 12:45 p.m. EDT on Sept. 9.
More on OMCL: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier OMCL move explainers: 2026-09-01 · 2026-08-31